The effectiveness of eplerenone in clinical practice from the standpoint of evidence-based medicine (twenty years on the guard of life)
The article focuses on the negative role of hyperaldosteronism in cardiovascular diseases and the possibility of its control when using a selective mineralocorticoid receptor antagonist – eplerenone. Based on numerous, multicenter clinical studies, the advantage of using eplerenone in the complex th...
Saved in:
| Main Authors: | A. G. Evdokimova, R. I. Stryuk, V. V. Evdokimov, A. K. Kaptaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2023-01-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/999 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01) -
A Prospective Crossover Clinical Trial of Esaxerenone and Eplerenone in Patients with Chronic Heart Failure Complicated by Hypertension
by: Akira Sezai, et al.
Published: (2025-05-01) -
Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
by: N. A. Nuritdinov, et al.
Published: (2020-12-01) -
PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01) -
Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2022-07-01)